The CRISPR Therapeutics AG Common Shares (CRSP) Receives New Coverage from Analysts at Citigroup Inc. – DailyQuint
|
The CRISPR Therapeutics AG Common Shares (CRSP) Receives New Coverage from Analysts at Citigroup Inc.
DailyQuint Citigroup Inc. started coverage on shares of CRISPR Therapeutics AG Common Shares (NASDAQ:CRSP) in a report issued on Tuesday morning. The brokerage issued a neutral rating and a $19.00 price target on the stock. Other analysts have also recently … |
